Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biosyntech Inc

BSYI
Current price
Last closed
Company
ISIN CA09068L1031
Sector Healthcare
Industry Biotechnology
Exchange PINK
Capitalization 229 033 USD
Yield for 12 month -100.00 %
1Y
3Y
5Y
10Y
15Y
BSYI
21.11.2021 - 28.11.2021

BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. Its lead products in development include BST-CarGel, a biodegradable gel for cartilage repair; BST-InPod for heel pain relief; BST-DermOn for chronic wound healing; BST-Ossifil for bone filling; BST-Ossifix for bone structural support; and BST-Disc for intervertebral disc restoration. The company's products also comprise BST-Gel-based injectable products that deliver biotherapeutics to their targeted site of action; Arthro-BST, an arthroscopic device used for the non-destructive evaluation of cartilage degradation and/or repair; and Mach-1, a micromechanical testing system for evaluating the mechanical properties of tissues and materials. In addition, it manufactures ultra pure chitosans under the Ultrasan name; and offers manufacturing and analytical services. The company was incorporated in 1994 and is based in Laval, Canada. On May 12, 2010, Biosyntech Inc. filed for administration under the Bankruptcy and Insolvency Act. Biosyntech Inc. is in reorganization. Address: 475 Armand-Frappier Boulevard, Laval, QC, Canada, H7V 4B3

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.5 USD

P/E ratio

Dividend Yield

Current Year

+3 638 USD

Last Year

+156 299 USD

Current Quarter

+232 USD

Last Quarter

+47 482 USD

Current Year

+2 213 USD

Last Year

+98 167 USD

Current Quarter

-186 USD

Last Quarter

+32 154 USD

Key Figures BSYI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 320 873 USD
Operating Margin TTM -306089 %
PE Ratio
Return On Assets TTM -51.93 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 0.5 USD
Revenue TTM 199 702 USD
Book Value -0.12 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -89.2 %
Dividend Yield
Gross Profit TTM 24 795 USD
Earnings per share
Diluted Eps TTM
Most Recent Quarter IV 2009
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BSYI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BSYI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 19:4
Payout Ratio
Last Split Date 10.01.2000
Dividend Date

Stock Valuation BSYI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.5831
Price Sales TTM 1.1469
Enterprise Value EBITDA -0.0099
Price Book MRQ

Financials BSYI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BSYI

For 52 weeks

0.003 USD
50 Day MA 0.0013 USD
Shares Short Prior Month
200 Day MA 0.0026 USD
Short Ratio
Shares Short
Short Percent